Background: Substance P (SP) is a peptide neurotransmitter found in central and peripheral nerves. SP is involved in the control of smooth muscle, inflammation and nociception. The amino acid sequence of SP is Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH 2 . Five different forms of fluorescently labeled SP have recently been synthesized, in which Alexa 488, BODIPY Fl, fluorescein, Oregon Green 488 or tetramethylrhodamine has been covalently linked to SP at Lys 3 . Here, these novel analogs are characterized as to their ligand binding, receptor activation and fluorescence labeling properties.
Background
Substance P (SP) is a peptide neurotransmitter that has been shown to play a role in nociception, smooth muscle control, allergic responses, inflammation and glandular secretion [1] . The amino acid sequence of SP was determined in 1970 [2] after being isolated from mammalian gastrointestinal tract in 1931 [3] . SP acts as an agonist at the SP receptor (SPR), known as the neurokinin-1 receptor (NK1) in mammalian systems. SP activation of the SPR, a G-protein-coupled receptor, has a variety of effects in the nervous system including inhibition of the Mtype K + current (I M ) [4] . The mechanistic properties of the SPR have been extensively studied in receptor-expression systems. When transfected into Chinese hamster ovary (CHO) cells, activation of the SPR results in an increase in intracellular Ca ++ [5] , accumulation of inositol phosphates and cAMP formation [6] .
The recent development of intense, photostable and pHinsensitive fluorophores, along with improvements in optical detection systems, has led to fluorophore labeling of many pharmacological agents. Fluorescent probes can be used to directly label ligand-binding sites without the use of radioactivity or antibodies. Receptor-labeling with a fluorophore-conjugated agonist provides advantages over these conventional methods. The production of antibodies to the receptor protein is not required, as the labeled agonist will bind directly to the receptor. Fluorescence rather than radioactivity can detect the labeled ligand, which provides more information on the localization of the receptor upon SP activation. In addition, labeled agonists can be used in live cells. Therefore, the use of fluorescently labeled agents may allow a more extensive investigation into various receptor functions.
Molecular Probes, Inc. (Eugene, OR) has recently synthesized five fluorophore-conjugated analogs of SP as potential tools for direct labeling of the SPR. Alexa 488, BODIPY Fl, fluorescein, Oregon Green 488 and tetramethylrhodamine have been conjugated to the third amino acid of SP, Lys
3
. The amine group of Lys provides a convenient reactive group for labeling SP without altering its original amino acid sequence. Alexa 488, BODIPY Fl, fluorescein and Oregon Green 488 are green fluorophores, while tetramethylrhodamine is a red fluorophore.
We have compared the receptor activation and labeling of five newly synthesized fluorescent analogs of SP. Each of the probes has been tested for: 1) ability to bind to the receptor, 2) receptor activation in both a heterologous expression system and in native neurons and 3) fluorescence labeling of the receptor. This study provides an extensive characterization of the new SP derivatives that will provide a basis for future studies involving the fluorescent conjugates. Oregon Green 488 was found to be the most useful fluorophore for labeling SP without altering its biological activity, whereas Alexa 488 drastically altered the binding and activation of SP.
Results

Spectra properties of fluorescent analogs
The fluorescent properties of a fluorophore can change when the fluorophore is attached to another molecule, in this case a peptide. Furthermore, the conditions under which fluorescence is measured, such as pH, ionic strength and buffer composition, can affect fluorescence.
The absorption and emission spectra of the fluorescent SP analogs were assessed to determine their fluorescence under experimental conditions used here. As shown in Fig. 2 , the peak excitations of Alexa 488-SP, BODIPY Fl-SP, fluorescein-SP, Oregon Green 488-SP and tetramethylrhodamine-SP were 490 nm, 505 nm, 495 nm, 495 nm and 560 nm, respectively. The peaks of the emission curves were 515 nm, 510 nm, 520 nm, 520 nm and 575 nm, respectively.
Epifluorescence microscopy
Direct-labeling of the SPR with fluorescent ligands like those analyzed in this study would offer advantages over current methods of receptor labeling. Some of these advantages include the ability to label live cells and the ability to conduct receptor labeling without antibodies or radioactive ligands. Therefore, an important characteristic of the fluorescent SP analogs is their ability to bind to the SPR and to fluoresce under physiological conditions. In order to observe the direct-labeling of the SP conjugates to the SPR, CHO cells expressing the rat SPR (rSPR), were incubated with the SP analogs (100 nM) for 2 hrs at 4°C, to prevent internalization of the receptor, rinsed and fixed. Under these conditions, all of the labeled forms of SP, except for Alexa 488-SP, produced bright membrane staining (Fig. 3) . Observation of transfected cells incubated with phosphate buffered saline (PBS) in the absence of labeled SP conjugate showed that the transfected cells had some intracellular auto-fluorescence (Fig. 3, F) . The fluorophore-treated cells also show some dull intracellular fluorescence, similar to the autofluorescence seen in the unstained control cells. The intensity of the staining produced by the green fluorophores was compared by quantitative analysis. The intensities of the fluorescence after staining with BOD-IPY Fl-SP, fluorescein-SP and Oregon Green 488-SP were significantly greater (p < 0.0001) than the intensity of the fluorescence of cells treated with Alexa 488-SP. Tetramethylrhodamine-SP also produced intense membrane staining. The intensity of the staining with tetramethylrhodamine-SP could not be directly compared to the others due to its different excitation and emission wavelengths.
The specificity of the fluorescence staining was revealed by the finding that unlabeled SP effectively prevented the fluorescent staining of rSPR-transfected CHO cells. The fluorescence of these cells was similar to that of transfected cells incubated in PBS alone (Fig. 3, F ) in that they possessed some intracellular auto-fluorescence but lacked membrane staining.
Application of the labeled analogs to untransfected CHO cells did not produce membrane staining (data not shown). Only intracellular auto-fluorescence, compara-ble to that observed with transfected cells incubated with PBS in the absence of labeled SP (Fig. 3, F) , was seen in cells lacking the rSPR.
SP receptor binding
An important determinant of the usefulness of the SP conjugates is their ability to bind to and activate the SPR. Therefore, the ability of each of the fluorescent SP analogs to compete with [ Two-way analysis of variance followed by Student-Newman-Keuls test showed that there was a dose-dependent effect (p < 0.001) on the binding of unlabeled SP and the SP analogs to the rSPR. Statistical analysis also demonstrated that the competition binding curves generated by the SP conjugates were significantly different than the unlabeled SP binding curve (p < 0.001). Further analysis showed that, with the exception of the binding curves produced by tetramethylrhodamine-SP and Oregon Green 488-SP, a significant difference was seen between the binding curves of the different SP conjugates (p < 0.05).
Calcium measurements
Activation of the SPR expressed in CHO cells results in an elevation in intracellular Ca ++ [7] . The biological activity of the SP conjugates was tested by examining their None of the labeled SP analogs produced Ca ++ elevations (n = 3) when added to untransfected CHO cells at a concentration of 10 nM (data not shown). When the fluorescent derivatives were added at a concentration of 100 nM they produced an increase in the fluorescence signal due to the inherent fluorescence of the probes. This could also be seen in the absence of cells. Due to this interference, the activity of the fluorescent probes to produce Ca ++ elevations could not be tested at concentrations higher than 10 nM.
Alexa 488-SP produced the most prominent increase in non-specific fluorescence in the absence of cells. 
Effects of SP analogs on single neurons
The data thus far show that the labeled forms of SP, with the exception of Alexa 488-SP, can bind to and activate the receptor in a heterologous expression system. It is also of importance to determine the activity of the labeled ligands in a cell that endogenously expresses the SPR. The principal neurons of bullfrog sympathetic ganglia express a SPR that has been well characterized with regard to its structure and function. The bullfrog sympathetic ganglia SPR (bfSPR) has 69% homology to the rSPR at the amino acid level. Perhaps most importantly, nine of the ten residues that have been demonstrated to be important for SP binding to mammalian receptors are conserved in the bullfrog receptor. The effects of SP and other tachykinins at the bfSPR have been previously well characterized [8, 9, 5] . The primary biological response following activation of the ganglionic SPR is inhibition of the M-type K + current, I M .
SP produces a dose-dependent inhibition of I M [9] . The responses of a given neuron to a given form of labeled SP have been compared to the responses of those same neurons to unlabeled SP at a concentration of 100 nM (Fig.  6 ). At this concentration SP typically elicits a 70 % depression of I M . BODIPY Fl-SP and Oregon Green 488-SP produced an inhibition of I M similar to that of unlabeled SP. Fluorescein-SP was variable in its ability to inhibit the current, being effective on only two of the four cells tested. At a concentration of 100 nM, neither Alexa 488-SP nor tetramethylrhodamine-SP inhibited I M ; thus they were further tested at a concentration of 1 µM. At this concentration tetramethylrhodamine-SP inhibited I M by 57 ± 33 %, (n = 4), however Alexa 488-SP did not inhibit I M . Dose-response curves for the analogs that inhibited I M and for unlabeled SP are shown in the plots in Fig. 6 . A dose-dependency was observed for the effects of BOD-IPY Fl-SP, fluorescein-SP and Oregon Green 488-SP.
Discussion
A number of previous studies have demonstrated that fluorescently labeled ligands are useful probes for studying ligand-receptor interactions [10, 11, 12] . Improved fluorophores, better optics and the increased sensitivity of detection systems have led to an increased usage of fluorescently labeled ligands. It is of vital importance that additions of fluorescent groups do not alter the normal functioning of the ligand, for example, by changing the binding affinity or by altering the receptor activation properties of the ligand. If the fluorescent group does alter the properties of the ligand, it is important that these alterations be understood so that the results obtained with the labeled ligand can be correctly interpreted. In this study, we have examined the fundamental consequences of labeling the neuropeptide SP with five different fluorescent probes by comparing the effects of the labeled compounds with those of the parent compound, SP.
All five of the fluorescent probes were modified at the Like Alexa 488, tetramethylrhodamine also adds a charge to SP, but tetramethylrhodamine-SP generated an IC 50 that was the most similar to that of unlabeled SP. This SP analog also produced intense staining and typical Ca ++ responses at the rSPR. However, tetramethylrhodamine-SP was ineffective at inhibiting I M at a 100 nM concentration, but did so upon increasing the concentration to 1 µM. Therefore, tetramethylrhodamine-SP is capable of binding to the SPR and activating Ca ++ responses, but has a decreased potency for inhibiting I M .
Lys 3 of SP has been shown to interact with the NH 2 -terminal extracellular tail (residues 1-21) of the mouse SPR [13] . Though residues 1-21 of the mouse SPR are primarily conserved in the rSPR, only 5 of the 21 residues are conserved in the bullfrog SPR. Given the importance of Lys 3 in the mouse SPR, it is therefore conceivable that an alteration in the charge of the parent compound, SP, as is the case with Alexa 488-SP and tetramethylrhodamine-SP, may cause a change in the typical actions of SP. The addition of Alexa 488 causes a greater change in the charge of SP, which might inhibit proper ligand-receptor interaction and thus hinder binding of the SP analog to the SPR. Tetramethylrhodamine also alters the charge of SP, but unlike Alexa 488, the fluorophore is positively charged. Perhaps the addition a single positive charge to SP by tetramethylrhodamine does not disrupt proper ligand/receptor interactions as drastically as the multiple negative charges that Alexa 488 adds to SP. Therefore, the less drastic charge alteration made by tetramethylrhodamine may allow the mechanistic characteristics of
Figure 5
Calcium dose response data for the effects of conjugated and unconjugated SP at the rSPR expressed in CHO cells. Values are the peak Ca ++ elevation produced by each drug expressed as the % of the ionomycin response for that coverslip. ANOVA showed significant dose-dependency, but no difference between Ca ++ responses produced by the drugs was shown. Each data point represents the average of at least 5 experiments. Alexa 488-SP is not graphed since it did not elicit specific Ca ++ responses at the rSPR. It is interesting to note that although there was a significant difference between the binding curves of the fluorescent derivatives of SP and unlabeled SP, there was not a statistically significant in the peptides' ability to produce dose-dependent Ca ++ elevations. These might be explained by the differences in the mechanisms that underlie the measurements made in the different experiments. Another study has examined the effects of fluorescent conjugation on opioid peptide activity [15] . Alexa 488 and BODIPY TR were used to label dermorphin, deltrophin, TIPP (Try-Tic-Phe-Phe) and endomorphin by adding a cysteine to each peptide at the C-terminus, followed by conjugation of the fluorophores to the cysteine residue. The investigators found that the dermorphin and deltorphin analogs had an increased binding affinity for the µ-and δ-opioid receptors, respectively, and that the biological activities of parent compounds were preserved. However, when Alexa 488 was conjugated to TIPP and endomorphin, the binding affinities of the parent compounds were decreased.
Buku et al. [16] synthesized two fluorescent probes for the vasotocin receptor using fluorescein and tetramethylrhodamine. These investigators had previously conjugated the fluorophores to the seventh position of vasotocin, a nonapeptide, and found that it had biological activity, but that the biological activity was reduced when compared to the native compound [17] . Therefore, the investigators conjugated the fluorophores to the ninth position and found that the analog was 10-fold more potent than the analog with the fluorophores at the seventh position. Thus, they concluded that by moving the bulky fluorophore to the end of vasotocin, and not altering an amino acid involved in binding and activation of the vasotocin receptor minimized the reduction in biological activity of the probes.
In summary, our results along with those from other labs show that, in some cases, conjugation of a specific fluorescent label can be added to a peptide without altering the activity of the parent compound. In other cases, however, the activity of the original compound may be drastically altered. Therefore, the biological activity of each novel fluorophore conjugate must be analyzed. Analysis of labeled compounds should include assessment of binding and biological activity as well as brightness and stability.
Conclusions
The results of our study show that there are dramatic differences in the function of SP labeled at the Lys 3 position with different fluorophores. Alexa 488, which was the largest and added the most charged groups to SP, was unable to label the SPR and altered the biological activity of SP in live and cultured cells. Oregon Green 488 and BODIPY Fl, which are smaller and uncharged, appear to be the most useful fluorophores for labeling SP without altering the normal functions of SP at the SPR regardless of the expression system. These results suggest that Oregon Green 488-SP and BODIPY Fl-SP would be the most useful fluorescent ligands for future studies of the SPR.
Materials and Methods
Labeled peptides SP labeled with Alexa 488 (S-13426), BODIPY Fl (S-13425), fluorescein (S-13424), Oregon Green 488 (S-13427) or tetramethylrhodamine (S-13428) on Lys 3 were purchased from Molecular Probes (Eugene, OR), product numbers in parenthesis. The chemical formulae for the labeled compounds are shown in Fig. 1 .
Spectra
Fluorophore spectral analysis was performed on a Perkin Elmer 512 Spectrofluorometer (Foster City, CA). Alexa 488-SP, BODIPY Fl-SP, fluorescein-SP, Oregon Green 488-SP and tetramethylrhodamine-SP were analyzed at a concentration of 10 nM, using PBS, pH 7.4, as a solvent.
Epifluorescence microscopy CHO cells stably transfected with the cDNA of the rSPR were obtained from Dr. James Krause and maintained as previously described [18] . Transfected CHO cells were cultured overnight on 3-well HTC super cured glass slides (Cel-Line Associates, Inc., Newfield, NJ). The following day, the slides were rinsed with PBS. Two of the three wells from each slide were stained with 100 nM of one of the SP conjugates. The third well of each slide served as a negative control, in that the cells were incubated with PBS in the absence of a SP analog. Slides were incubated for 2 hrs at 4°C, to prevent internalization of the receptor and thus provide membrane staining. The cells were then rinsed and fixed with paraformaldehyde (2 %) (Fisher Scientific, Pittsburgh, PA) at 4°C for 20 min. Slides were viewed under a Nikon Eclipse E600FN fluorescent microscope (Fryer Company, Inc., Cincinnati, OH). The green fluorophores were excited using a FITC (fluorescein isothiocyanate) filter set (excitation 465-495 nm, dichroic 505LP, emission 515-555 nm). The red fluorophore was excited using a TRITC (tetramethylrhodamine isothiocyanate) filter set (excitation 528-553 nm, dichroic 565LP, emission 600-660 nm). Pictures were taken with a SPOT camera (Diagnostic Instruments, Inc., Sterling Heights, MI). All digital images of the green fluorophores were taken at a constant gain (16) and exposure time (0.7 s) to allow for direct comparison between cells and experiments. Pictures of tetramethylrhodamine-SP, the red fluorophore, were taken at a gain of 8 and a 0.4 s exposure time.
The specificity of the fluorescent staining to the rSPR was analyzed in two ways. First, incubating untransfected CHO cells with 100 nM of each analog assessed nonspecific staining. Secondly, staining of rSPR-transfected CHO cells was performed in the presence of an excess of unlabeled SP. Transfected cells were pretreated with 1 µM unlabeled SP for 1 hr at 4°C. Then, the cells were rinsed and incubated with 1 µM unlabeled SP and 100 nM labeled SP for 1 hr at 4°C. The cells were rinsed, fixed and viewed as described above.
Image Analysis
Epifluorescence images from the wells containing only conjugated SP (100 nM) were analyzed using Scion Image (Scion Corporation, Frederick, MD). For each fluorophore, except tetramethylrhodamine, a line was drawn around the outside of the cell membrane of 10 cells (5 cells/experiment) to create a boundary; the area and pixel intensity were then measured within each boundary. Background, as determined by measuring the intensity and area of 10 control cells incubated with PBS in the absence of a fluorophore, was subtracted. Cell area was used to normalize between cells, thus the ratio of intensity to area was calculated for the treated and untreated cells. 
Receptor binding
Calcium measurements
Dose-response curves for the ability of the SP analogs to produce Ca ++ elevations upon binding to the SPR were obtained as previously described [5] . Briefly, transfected CHO cells expressing the rSPR were cultured onto coverslips until ∼ 90% confluent. The coverslips were incubated in a Ca Two experiments were carried out to serve as negative controls. In the first control experiment, untransfected CHO cells were utilized to determine if any of the SP conjugates were eliciting Ca ++ responses through a pathway independent of rSPR activation. Each of the SP isoforms was added to untransfected CHO cells at a concentration of 10 nM and the signals, if any, were recorded. If a SP conjugate caused an increase in Ca ++ at 10 nM, then 0.1 and 1 nM concentrations for that fluorophore were also tested.
The second control experiment measured fluorescence produced by the SP analogs themselves, in the absence of cells. Each of the SP fluorophores was added to the Ca ++ solution in the absence of cells at a concentration of 10 nM and increases in fluorescence, if any, were recorded. If a response was observed at a 10 nM concentration, then 0.1 and 1 nM concentrations were also tested for that SP analog. If a SP analog produced a Ca ++ elevation in either control assay, then the average (n of 3) for the differences between the baseline and peak Ca ++ signals for that concentration was calculated. The average was then subtracted from the Ca ++ responses observed when that SP analog was added to transfected and untransfected CHO cells at that concentration.
Electrophysiology
Single neurons were dissociated from bullfrog sympathetic ganglia as described previously [19] . Briefly, ganglia were dissected, treated with enzymes and then stored in growth medium at 4°C for 1 to 3 days. The ganglia were triturated to release single neurons for daily use.
Whole cell recordings of isolated neurons were conducted at room temperature, ∼ 21°C. Drugs were applied by single cell superfusion [20] I M was monitored by 500 ms pulses from a holding potential of -30 mV to -50 mV every 8 s. The recordings were filtered at 1 kHz and stored on magnetic tape. The I M relaxations were sampled on line at 2.4 kHz. I M was measured as the amplitude of the current tail following a voltage step from -50 mV to -30 mV [21] . To quantify the inhibition of I M , the current before drug and at the maximum inhibition during each response were measured and the percentage of inhibition of I M was calculated.
Statistical Analysis
The percent of ionomycin data from the Ca ++ elevation experiments and the B/B 0 data from the binding experiments were both subjected to two-way ANOVA analysis, with the independent variables being fluorescent conjugate and dose. One-way ANOVA analysis was used to describe the intensity to area measurements from the fluorescent images, except tetramethylrhodamine. These data, like the data obtained from the binding assay and Ca ++ analysis, were analyzed for variance followed by the Student-Newman-Keuls test.
